跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,414 条关于
“Immunoglobulin Subcutaneous 20%”
全部
15,414
临床试验
7,087
药物
1,089
机构
129
资讯
7,109
4年前
Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency
去年
Subcutaneous Immunoglobulin with Hyaluronidase Shows Promise for Idiopathic Inflammatory Myositis Treatment
2年前
FDA Approves Expanded Label for Grifols' Xembify, Allowing Treatment-Naïve PI Patients Subcutaneous Immunoglobulin Therapy
去年
PALOMA-2 Study Confirms Efficacy of Subcutaneous Amivantamab in EGFR Exon 20 Insertion NSCLC
去年
Efgartigimod Shows Promise as Novel Therapy for CIDP
7个月前
Takeda Launches GAMMAGARD LIQUID ERC, First Ready-to-Use Low-IgA Immunoglobulin Therapy in U.S.
去年
Grifols' Immunoglobulin Therapy Shows Promising Results in Post-Polio Syndrome Clinical Trial
2个月前
Grifols Doses First Patients in Two Phase 3 Trials to Expand Labels for Gamunex-C and Xembify
去年
Inebilizumab Shows Promise in Reducing Flares of IgG4-Related Disease
去年
Large Real-World Study Questions Effectiveness of Immunoglobulin Replacement Therapy in CLL Patients
第 1 页，共 711 页
上一页
下一页
